IL101544A - 2-Aryl-3-) is converted to piperidino (carbonylacenyl pyrazolo] A-1,5 [pyridines, processes for their preparation, and pharmaceutical preparations containing them - Google Patents
2-Aryl-3-) is converted to piperidino (carbonylacenyl pyrazolo] A-1,5 [pyridines, processes for their preparation, and pharmaceutical preparations containing themInfo
- Publication number
- IL101544A IL101544A IL10154492A IL10154492A IL101544A IL 101544 A IL101544 A IL 101544A IL 10154492 A IL10154492 A IL 10154492A IL 10154492 A IL10154492 A IL 10154492A IL 101544 A IL101544 A IL 101544A
- Authority
- IL
- Israel
- Prior art keywords
- alkyl
- compound
- salt
- formula
- carboxy
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Cardiology (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Immunology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Urology & Nephrology (AREA)
- Obesity (AREA)
- Pulmonology (AREA)
- Child & Adolescent Psychology (AREA)
- Physical Education & Sports Medicine (AREA)
- Endocrinology (AREA)
- Transplantation (AREA)
- Reproductive Health (AREA)
- Vascular Medicine (AREA)
- Rheumatology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Position Input By Displaying (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB919107513A GB9107513D0 (en) | 1991-04-10 | 1991-04-10 | Pyrazolopyridine compound and processes for preparation thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
IL101544A0 IL101544A0 (en) | 1992-12-30 |
IL101544A true IL101544A (en) | 1996-06-18 |
Family
ID=10692949
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL10154492A IL101544A (en) | 1991-04-10 | 1992-04-09 | 2-Aryl-3-) is converted to piperidino (carbonylacenyl pyrazolo] A-1,5 [pyridines, processes for their preparation, and pharmaceutical preparations containing them |
Country Status (23)
Country | Link |
---|---|
US (1) | US5234930A (hu) |
EP (1) | EP0516941B1 (hu) |
JP (2) | JP2546470B2 (hu) |
KR (1) | KR100248700B1 (hu) |
CN (2) | CN1041203C (hu) |
AT (1) | ATE146473T1 (hu) |
AU (1) | AU653007B2 (hu) |
CA (1) | CA2065644C (hu) |
DE (1) | DE69215965T2 (hu) |
DK (1) | DK0516941T3 (hu) |
ES (1) | ES2095976T3 (hu) |
FI (1) | FI100969B (hu) |
GB (1) | GB9107513D0 (hu) |
GR (1) | GR3022113T3 (hu) |
HU (2) | HU214871B (hu) |
IE (1) | IE921086A1 (hu) |
IL (1) | IL101544A (hu) |
MX (1) | MX9201672A (hu) |
NO (1) | NO300271B1 (hu) |
RU (1) | RU2069662C1 (hu) |
SG (1) | SG43917A1 (hu) |
TW (1) | TW205550B (hu) |
UA (1) | UA27252C2 (hu) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5541213A (en) * | 1993-06-24 | 1996-07-30 | Eisai Co., Ltd. | Propenoic acid derivatives diazole propenoic acid compounds which have useful pharmaceutical utility |
HUT76280A (en) * | 1993-12-29 | 1997-07-28 | Fujisawa Pharmaceutical Co | Pyrazolopyridine derivatives, pharmaceutical compositions containing them, process for proiducing them and their use |
WO1997040047A1 (fr) * | 1996-04-25 | 1997-10-30 | Fujisawa Pharmaceutical Co., Ltd. | Medicaments pour la prevention et le traitement des lesions et de l'ileus par ischemie intestinale |
AUPO111096A0 (en) * | 1996-07-18 | 1996-08-08 | Fujisawa Pharmaceutical Co., Ltd. | New compound |
WO1998041237A1 (fr) * | 1997-03-18 | 1998-09-24 | Fujisawa Pharmaceutical Co., Ltd. | Medicaments pour la prevention et la therapie de l'hyperphosphatemie |
ES2273487T3 (es) * | 1998-06-01 | 2007-05-01 | Astellas Pharma Inc. | Antagonistas a1 de adenosina contra la esterilidad masculina. |
US20040152659A1 (en) * | 1999-05-12 | 2004-08-05 | Fujisawa Pharmaceutical Co. Ltd. | Method for the treatment of parkinson's disease comprising administering an A1A2a receptor dual antagonist |
PE20020506A1 (es) * | 2000-08-22 | 2002-07-09 | Glaxo Group Ltd | Derivados de pirazol fusionados como inhibidores de la proteina cinasa |
US6919352B2 (en) | 2000-12-15 | 2005-07-19 | Smithkline Beecham Corporation | Pyrazolopyridinyl pyridine and pyrimidine therapeutic compounds |
DE60112330T2 (de) * | 2000-12-15 | 2006-04-13 | Glaxo Group Ltd., Greenford | Pyrazolopyridinderivate |
US7153855B2 (en) * | 2001-03-08 | 2006-12-26 | Smithkline Beecham Corporation | Pyrazolopyridinyl pyrimidine therapeutic compounds |
US7034030B2 (en) * | 2001-03-30 | 2006-04-25 | Smithkline Beecham Corporation | Pyralopyridines, process for their preparation and use as therapeutic compounds |
EP1372642A1 (en) * | 2001-03-30 | 2004-01-02 | SmithKline Beecham Corporation | Use of pyrazolopyridines as therapeutic compounds |
WO2002083672A1 (en) | 2001-04-10 | 2002-10-24 | Smithkline Beecham Corporation | Antiviral pyrazolopyridine compounds |
ES2242028T3 (es) | 2001-04-27 | 2005-11-01 | Smithkline Beecham Corporation | Derivados de pirazolo(1,5-a)piridina. |
AUPR548601A0 (en) * | 2001-06-06 | 2001-06-28 | Fujisawa Pharmaceutical Co., Ltd. | Pyrazolopyrazinecompound and pharmaceutical use thereof |
CN1518550A (zh) * | 2001-06-21 | 2004-08-04 | ʷ��˿�������ȳ�ķ����˾ | 用于预防和治疗疱疹病毒感染的咪唑并[1,2-a]吡啶衍生物 |
ATE364043T1 (de) * | 2001-09-07 | 2007-06-15 | Smithkline Beecham Corp | Pyrazolo-pyridine für die behandlung von herpes- ansteckungen |
JP2005508955A (ja) * | 2001-10-05 | 2005-04-07 | スミスクライン ビーチャム コーポレーション | ヘルペスウイルス感染の治療で使用されるためのイミダゾ−ピリジン誘導体 |
WO2003050120A1 (en) * | 2001-12-11 | 2003-06-19 | Smithkline Beecham Corporation | Pyrazolo-pyridine derivatives as antiherpes agents |
JP2006504728A (ja) * | 2002-10-03 | 2006-02-09 | スミスクライン ビーチャム コーポレーション | ピラソロピリジン誘導体系治療用化合物 |
BRPI0712381A2 (pt) | 2006-06-06 | 2012-07-10 | Avigen Inc | compostos de pirazolo[1,5-a]piridina substituìda e seus métodos de uso |
US9572528B1 (en) | 2012-08-06 | 2017-02-21 | Los Angeles Biomedical Research Insitute at Harbor-UCLA Medical Center | Monitor for SIDS research and prevention |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4925849A (en) * | 1987-06-15 | 1990-05-15 | Fujisawa Pharmaceutical Company, Ltd. | Pharmaceutically useful pyrazolopyridines |
GB8901423D0 (en) * | 1989-01-23 | 1989-03-15 | Fujisawa Pharmaceutical Co | Pyrazolopyridine compound and processes for preparation thereof |
-
1991
- 1991-04-10 GB GB919107513A patent/GB9107513D0/en active Pending
-
1992
- 1992-04-02 AU AU13988/92A patent/AU653007B2/en not_active Expired
- 1992-04-02 TW TW081102547A patent/TW205550B/zh active
- 1992-04-03 IE IE108692A patent/IE921086A1/en not_active IP Right Cessation
- 1992-04-07 FI FI921522A patent/FI100969B/fi not_active IP Right Cessation
- 1992-04-08 SG SG1996005302A patent/SG43917A1/en unknown
- 1992-04-08 DK DK92106028.1T patent/DK0516941T3/da active
- 1992-04-08 AT AT92106028T patent/ATE146473T1/de active
- 1992-04-08 ES ES92106028T patent/ES2095976T3/es not_active Expired - Lifetime
- 1992-04-08 EP EP92106028A patent/EP0516941B1/en not_active Expired - Lifetime
- 1992-04-08 DE DE69215965T patent/DE69215965T2/de not_active Expired - Lifetime
- 1992-04-09 US US07/866,215 patent/US5234930A/en not_active Expired - Lifetime
- 1992-04-09 CN CN92103372A patent/CN1041203C/zh not_active Expired - Lifetime
- 1992-04-09 RU SU5011507/04A patent/RU2069662C1/ru active
- 1992-04-09 CA CA002065644A patent/CA2065644C/en not_active Expired - Lifetime
- 1992-04-09 IL IL10154492A patent/IL101544A/en not_active IP Right Cessation
- 1992-04-09 CN CNB971253781A patent/CN100508975C/zh not_active Expired - Lifetime
- 1992-04-09 HU HU9201213A patent/HU214871B/hu unknown
- 1992-04-09 NO NO19921413A patent/NO300271B1/no not_active IP Right Cessation
- 1992-04-09 KR KR1019920005893A patent/KR100248700B1/ko not_active IP Right Cessation
- 1992-04-09 JP JP4088735A patent/JP2546470B2/ja not_active Expired - Lifetime
- 1992-04-10 MX MX9201672A patent/MX9201672A/es unknown
-
1993
- 1993-06-18 UA UA93002532A patent/UA27252C2/uk unknown
-
1995
- 1995-06-22 HU HU95P/P00354P patent/HU211680A9/hu unknown
- 1995-11-16 JP JP7298193A patent/JP2903040B2/ja not_active Expired - Fee Related
-
1996
- 1996-12-19 GR GR960403475T patent/GR3022113T3/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5234930A (en) | Pyrazolopyridine compounds which have useful pharmaceutical utility | |
US4797406A (en) | Amides and esters containing bridged piperidines and use as serotonin M antagonists | |
US5773530A (en) | Pyrazolopyridine adenosine antagonists | |
JP3993651B2 (ja) | シクロプロパクロメンカルボン酸誘導体 | |
JPH07188165A (ja) | 5,6−双環性グリコプロテインIIb/IIIa拮抗剤 | |
RU2261860C2 (ru) | ЗАМЕЩЕННЫЕ В ПОЛОЖЕНИИ 8А ПРОИЗВОДНЫЕ 8,8А-ДИГИДРОИНДЕНО [1,2-d] ТИАЗОЛА, СПОСОБ ИХ ПОЛУЧЕНИЯ И ИХ ПРИМЕНЕНИЕ В КАЧЕСТВЕ ЛЕКАРСТВЕННЫХ СРЕДСТВ, НАПРИМЕР В КАЧЕСТВЕ АНОРЕКСИЧЕСКИХ СРЕДСТВ | |
WO1992001668A1 (en) | Benzoic acid substituted derivatives having cardiovascular activity | |
JP2000511173A (ja) | 一酸化窒素産生阻害剤としての新規なインドリルおよびベンゾフラニルカルボキサミド | |
JP5181674B2 (ja) | 光学活性なジヒドロピリジン誘導体の酸付加塩 | |
EP0453960B1 (en) | Sulfonylamino substituted bicyclyl hydroxamic acid derivatives | |
JP4261639B2 (ja) | フェニルイミダゾール系抗高脂血症薬 | |
JPH06199866A (ja) | ジアゼピン誘導体 | |
JPH0358987A (ja) | 新規化合物、その製法及びそれを含む医薬組成物 | |
JP3585838B2 (ja) | チアジアゾロ〔4,3−a〕ピリジン誘導体の使用 | |
US6235763B1 (en) | Polycyclic 2-aminodihydrothiazole systems, processes for their preparation and their use as pharmaceuticals | |
US20230017312A1 (en) | Centrally active p38alpha inhibiting compounds | |
JP2005239611A (ja) | ピラゾロピリミジン誘導体およびその用途 | |
EP0738705B1 (en) | Gamma-diketone compound having platelet aggregation inhibiting effect | |
KR101646093B1 (ko) | 세로토닌 활성을 가진 화합물, 이의 제조 방법 및 이를 포함하는 약학적 조성물 | |
ES2238015B1 (es) | Derivados de cicloalcanodionas con actividad neuroprotectora. | |
JPH04330060A (ja) | ピリジン−2,4−および−2,5−ジカルボン酸のジ(ニトロキシアルキル)アミド、その製造方法およびその使用 | |
HU190969B (en) | Process for preparing aminoalkyl-imidazo-thidaiazolyl-alkane-carboxylic acid amides and pharmaceutical compositions thereof as active substances | |
JPH0820586A (ja) | 1−アザビシクロ[3.3.0]オクタン誘導体、その塩及び製法並びに用途 | |
RU2252219C2 (ru) | Производные индено-, нафто- и бензоциклогептадигидротиазола, их получение и их применение в качестве анорексических лекарственных средств | |
JPH05339223A (ja) | 三環式化合物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FF | Patent granted | ||
KB | Patent renewed | ||
KB | Patent renewed | ||
KB | Patent renewed | ||
HC | Change of name of proprietor(s) | ||
KB | Patent renewed | ||
KB | Patent renewed | ||
EXP | Patent expired |